Skip to main content

Day: February 23, 2026

LiveOne (Nasdaq: LVO) App Now Available on VIZIO Smart TVs

Enables millions of VIZIO customers free 24/7 access to music, podcasts, and live events directly from their smart TVsExpands LiveOne’s B2B distribution to over 1.3+ billion monthly active users (MAUs) including Apple, Spotify, ART19, YouTube, Paramount, Telly, Telsa, DAX, TextNow and othersExpects at least two additional Fortune 250 B2B partnerships by year-endLOS ANGELES, Feb. 23, 2026 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), a creator-first music, entertainment, and technology platform, today announced the addition of its award-winning app on VIZIO and on smart TVs with VIZIO OS. Now, VIZIO customers have easy round-the-clock access to LiveOne’s music service on their connected devices, for free, via the LiveOne app. LiveOne is a comprehensive entertainment hub for music, podcasts, and live video content, with features...

Continue reading

INmune Bio to Detail XPro1595 Registrational Strategy in Upcoming Alzheimer’s Webinar

Webinar on February 27 at 9:30 AM ET will have key opinion leaders discuss recent and upcoming clinical development of XPro1595 Boca Raton, FL, Feb. 23, 2026 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (“INmune” or the “Company”), a late-stage biotechnology company focused on inflammation and immunology, will host a webinar focused on the registrational pathway of XPro1595 (“XPro™”) for the treatment of early Alzheimer’s disease on February 27, 2026 at 9:30 a.m. ET. Post the completion of the Phase 2 MINDFuL trial, along with feedback from the FDA in a recent End-Of-Phase 2 meeting, the Company has received alignment supporting advancement to a registrational study in patients with Alzheimer’s Disease with biomarkers of Inflammation. Webinar Focus: From Phase 2 Results to Phase 3 Readiness XPro™ is a next-generation,...

Continue reading

UPDATE: Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million

MIAMI, Feb. 23, 2026 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc. (“Cyprium”), today announced that Cyprium entered into a definitive asset purchase agreement to sell its Rare Pediatric Disease Priority Review Voucher (“PRV”) for gross proceeds of $205 million upon the closing of the transaction. In December 2023, Sentynl Therapeutics, Inc. (“Sentynl”) assumed full responsibility for the development and commercialization of ZYCUBO® (copper histidinate, formerly known as CUTX-101) from Cyprium. The PRV was issued upon approval of ZYCUBO by the U.S. Food and Drug Administration (“FDA”) on January 12, 2026. Pursuant to the transaction with Sentynl, the PRV was immediately transferred to Cyprium. Cyprium remains eligible to receive tiered royalties...

Continue reading

Consolidated Water to Attend the 38th Annual ROTH Conference, March 22-24, 2026

GEORGE TOWN, Cayman Islands, Feb. 23, 2026 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water treatment plants, has been invited to attend the 38th Annual ROTH Conference being held at The Ritz-Carlton Laguna Niguel in Dana Point, California, on March 22-24, 2026.The conference will feature on-demand presentations by companies across a range of industry sectors, in-person one-on-one and small group meetings, industry panels, and fireside chats. Past conferences have attracted more than 5,000 participants, comprised of institutional investors, family offices, high-net-worth investors, and equity analysts. On March 23-24, Consolidated Water CEO, Rick McTaggart, will participate in one-on-one meetings with analysts and investors. He will...

Continue reading

Schouw & Co. share buy-back programme, week 8 2026

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK    Accumulated until 13 February 2026 70,283 675.71 47,491,115    Monday, 16 February 2026 1,000 706.00 706,000    Tuesday, 17 February 2026 1,000 703.00 703,000    Wednesday, 18 February 2026 2,000 703.00 1,406,000    Thursday, 19 February 2026 1,000 697.00 697,000    Friday,...

Continue reading

Savaria Announces Date for Fourth Quarter 2025 Financial Results

LAVAL, Quebec, Feb. 23, 2026 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS) one of the global leaders in the accessibility industry, announces it will release its financial results for the fourth quarter of 2025 after market closes on March 4, 2026. Savaria’s management will hold an investor conference call and webcast at 8:30 a.m. Eastern Standard Time (EST) on Thursday, March 5, 2026. Investors and members of the media are invited to participate on a listen-only basis. Conference call access: https://register-conf.media-server.com/register/BI11584c57606d4117a7bc686702e48569 To access the conference call, you must register online and choose the method to join the call, either by dialing the number provided to you or by entering your phone number to receive a call from the system. Webcast URL (EN): https://edge.media-server.com/mmc/p/gd2pkz3c About...

Continue reading

Century Aluminum to Participate in BMO 2026 Global Metals, Mining & Critical Minerals Conference

CHICAGO, Feb. 23, 2026 (GLOBE NEWSWIRE) — Century Aluminum Company (NASDAQ: CENX) today announced that Jesse Gary, Century’s President and Chief Executive Officer, will present and participate in a question-and-answer session at the BMO Global Metals, Mining, & Critical Minerals Conference, beginning at approximately 8:15 a.m. EST on Tuesday, February 24, 2026. A real-time audio webcast of this session will be available on the “Investors” section of Century’s website www.centuryaluminum.com. About Century Aluminum CompanyWith its corporate headquarters located in Chicago, IL, Century Aluminum owns and operates primary aluminum smelting facilities in the United States and Iceland and is the majority owner and managing partner of the Jamalco alumina refinery in Jamaica. Visit  www.centuryaluminum.com for more information. Cautionary...

Continue reading

TIAN RUIXIANG in Advanced Talks to Combine With An Asia-Pacific Leading InsurTech In Addition to Advancing Its 15,000 Bitcoin Acquisition Strategy

BEIJING, CHINA, Feb. 23, 2026 (GLOBE NEWSWIRE) — TIAN RUIXIANG Holdings Ltd (NASDAQ: TIRX) (“Tian Ruixiang” or the “Company”), today confirms that it is in advanced and final-stage discussions for a transformative strategic business combination with a pre-eminent insurance technology (“InsurTech”) leader operating across the Asia-Pacific region. In addition, the Company continues to progress its previously announced Bitcoin (BTC) acquisition strategy as part of its broad initiative to enhance long-term shareholder value. This Asia-Pacific InsurTech leader is a well-capitalized, high-growth regional powerhouse with proprietary AI-driven underwriting, digital distribution, automated claims processing, and scalable operations across key high-growth markets in Asia. It has a strong track record of innovation, robust revenue growth,...

Continue reading

SafeSpace Global Corporation Transitions from Pre-Revenue to Active Revenue Generation with Eight Contracted Senior Living Facility Installations

Company Begins Recurring Monthly Revenue Stream in February 2026 through Deployment of AI-powered, Privacy-Aware Technology that Replaces Wearables and Loud Alarms with Proactive and Dignified Resident Safety KNOXVILLE, TN., Feb. 23, 2026 (GLOBE NEWSWIRE) — SafeSpace Global Corporation (OTCID: SSGC) (SafeSpace Global or the Company), a leader in AI-powered safety and security solutions, today announced that it has commenced revenue-generating operations with the installation of its technology across eight senior living facilities under executed service agreements. These contracts, which became active in February 2026, represent the Company’s transition from a pre-revenue development stage company to an operating company with recurring monthly revenue streams. This marks the first deployment of its AI-powered, multimodal platform...

Continue reading

Algorhythm Holdings Strengthens Balance Sheet with $9.5 Million Capital Infusion, Fully Capitalized for 2026 Growth Plan

Funding Positions Company to Execute Global Growth Strategy for SemiCab Platform Fort Lauderdale, FL, Feb. 23, 2026 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME) – a leading AI technology company, today announced it has received an additional $9.5 million under its existing $20 million financing facility, bringing total capital raised under the facility to $19.5 million. At completion of this new funding, Algorhythm reported approximately $12.5 million in cash on hand, providing ample capital to support the continued expansion of its SemiCab platform in India, the U.S., and other international markets. “We are now fully funded to execute our business plan in the US and India through 2026,” said Gary Atkinson, CEO of Algorhythm Holdings. “Our focus is singular: scaling SemiCab globally to transform truckload...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.